Literature DB >> 21248654

Immediate splenectomy decreases mortality and improves cognitive function of rats after severe traumatic brain injury.

Mei Li1, Fei Li, Chunxia Luo, Youan Shan, Lijun Zhang, Zhongming Qian, Gang Zhu, Jiangkai Lin, Hua Feng.   

Abstract

BACKGROUND: Traumatic brain injury (TBI) is a major health problem all over the world. It frequently causes a considerable social burden because of its high incidence of death and long-term disability, especially in the case of severe TBI. Recent studies revealed that the spleen might contribute to secondary brain injury after ischemia or intracerebral hemorrhage. The purpose of this study was to evaluate the significance of the spleen in traumatic brain edema after severe TBI.
METHODS: We established a severe TBI model with rats and performed splenectomy to observe the mortality, brain water content, cognitive function (water maze), and cytokines levels, including interleukin (IL)-1β, tumor necrosis factor-α (TNF-α), IL-6, and IL-10, in the blood plasma (enzyme-linked immunosorbent assay) and their mRNA expression levels in injured brain tissue (quantitative reverse transcriptase-polymerase chain reaction).
RESULTS: The immediate splenectomy after TBI significantly decreased the death rate from 35.42% to 14.89% and eliminated the brain water content of the injured brain, especially at days 2 and 3. The Morris water maze assessment showed an improved spatial reference memory in rats that underwent both TBI and splenectomy when compared with those in the TBI group, 4 weeks later. Splenectomy reduced the IL-1β, TNF-α, and IL-6 contents in the blood serum after TBI, and the mRNA expression levels of IL-1β, TNF-α, and IL-6 in the ipsilateral brain tissue also decreased.
CONCLUSIONS: Our study demonstrates that splenectomy has a protective effect on rats with severe TBI by inhibiting proinflammatory cytokines, including IL-1β, TNF-α, and IL-6, both systematically and locally in the injured brain, hence leading to a decreased mortality and improved cognitive function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21248654     DOI: 10.1097/TA.0b013e3181f30fc9

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  37 in total

1.  Brain-Spleen Inflammatory Coupling: A Literature Review.

Authors:  J Rasouli; R Lekhraj; M Ozbalik; P Lalezari; D Casper
Journal:  Einstein J Biol Med       Date:  2011

2.  Ultrasound prevents renal ischemia-reperfusion injury by stimulating the splenic cholinergic anti-inflammatory pathway.

Authors:  Joseph C Gigliotti; Liping Huang; Hong Ye; Amandeep Bajwa; Kryt Chattrabhuti; Sangju Lee; Alexander L Klibanov; Kambiz Kalantari; Diane L Rosin; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2013-08-01       Impact factor: 10.121

3.  Inflammatory consequences in a rodent model of mild traumatic brain injury.

Authors:  J Regino Perez-Polo; Harriet C Rea; Kathia M Johnson; Margaret A Parsley; Geda C Unabia; Guojing Xu; Smitha K Infante; Douglas S Dewitt; Claire E Hulsebosch
Journal:  J Neurotrauma       Date:  2013-05-06       Impact factor: 5.269

4.  Targeting the peripheral inflammatory response to stroke: role of the spleen.

Authors:  Keith R Pennypacker
Journal:  Transl Stroke Res       Date:  2014-09-26       Impact factor: 6.829

Review 5.  Stem cells and G-CSF for treating neuroinflammation in traumatic brain injury: aging as a comorbidity factor.

Authors:  I Dela Peña; P R Sanberg; S Acosta; N Tajiri; S Z Lin; C V Borlongan
Journal:  J Neurosurg Sci       Date:  2014-05-20       Impact factor: 2.279

6.  Systemic Estrone Production and Injury-Induced Sex Hormone Steroidogenesis after Severe Traumatic Brain Injury: A Prognostic Indicator of Traumatic Brain Injury-Related Mortality.

Authors:  Milap V Rakholia; Raj G Kumar; Byung-Mo Oh; Prerna R Ranganathan; Sarah L Berga; Patrick M Kochanek; Amy K Wagner
Journal:  J Neurotrauma       Date:  2018-08-24       Impact factor: 5.269

7.  A transient decrease in spleen size following stroke corresponds to splenocyte release into systemic circulation.

Authors:  Hilary A Seifert; Aaron A Hall; Cortney B Chapman; Lisa A Collier; Alison E Willing; Keith R Pennypacker
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-06       Impact factor: 4.147

8.  Intravenous transplants of human adipose-derived stem cell protect the brain from traumatic brain injury-induced neurodegeneration and motor and cognitive impairments: cell graft biodistribution and soluble factors in young and aged rats.

Authors:  Naoki Tajiri; Sandra A Acosta; Md Shahaduzzaman; Hiroto Ishikawa; Kazutaka Shinozuka; Mibel Pabon; Diana Hernandez-Ontiveros; Dae Won Kim; Christopher Metcalf; Meaghan Staples; Travis Dailey; Julie Vasconcellos; Giorgio Franyuti; Lisa Gould; Niketa Patel; Denise Cooper; Yuji Kaneko; Cesar V Borlongan; Paula C Bickford
Journal:  J Neurosci       Date:  2014-01-01       Impact factor: 6.167

9.  Progenitor cells: therapeutic targets after traumatic brain injury.

Authors:  Robert A Hetz; Supinder S Bedi; Scott Olson; Alex Olsen; Charles S Cox
Journal:  Transl Stroke Res       Date:  2012-05-22       Impact factor: 6.829

10.  CCL20 Is Associated with Neurodegeneration Following Experimental Traumatic Brain Injury and Promotes Cellular Toxicity In Vitro.

Authors:  Christopher C Leonardo; James Musso; Mahasweta Das; Derrick D Rowe; Lisa A Collier; Shyam Mohapatra; Keith R Pennypacker
Journal:  Transl Stroke Res       Date:  2012-08-09       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.